Intravenous antidepressant treatment: Focus on citalopram

European Archives of Psychiatry and Clinical Neuroscience

Volumn 252, Issue 3, 2002, Pages 105-109

  Kasper, S ^a   Muller Spahn F ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Antidepressant; Citalopram; Infusion; SSRI; Viloxazine clomipramine

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; PLACEBO; SEROTONIN UPTAKE INHIBITOR; VILOXAZINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG INFUSION; DRUG TOLERABILITY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NAUSEA; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TREATMENT OUTCOME; TREMOR; VERTIGO;

ADMINISTRATION, ORAL; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFUSIONS, INTRAVENOUS; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS;

EID: 0036944231     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-002-0363-8     Document Type: Article

References (31)

1. Adler L, Hajak G, Lehmann K, Kunert HJ, Hoffmann G, Issinger J, Boke J, Huether G, Ruether E (1997) On the problems of switching from intravenous to oral administration in drug treatment of endogenous depression. Pharmacopsychiatry 30:62-69
2. American Psychiatric Association (APA) (1987) Diagnostic and statistical manual for mental disorders, 3rd edition (revised). Washington DC: American Psychiatric Association
3. Angst J (1999) Major depression in 1998: are we providing optimal therapy? J Clin Psychiatry 60 (Suppl. 6):5-9
4. Baumann P, Larsen F (1995) The pharmacokinetics of citalopram. Rev Contemp Pharmacother 6:287-295
5. Baumann P, Nil R, Bertschy G (1998) A double-blind, double-dummy study of citalopram comparing infusion versus oral administration. J Affect Disord 49:203-210
6. Bouchard JM, Strub N, Nil R (1997) Citalopram and viloxazine in the treatment of depression by means of slow drop infusion. A double-blind comparative trial. J Affect Disord 46:51-58
7. Brückmann JU, Blaha L (1982) Katamnestische Beurteilungen des Therapieerfolges antidepressiver Infusionsbehandlung. In: Kielholz P, Adams C (eds) Antidepressive Infusionstherapie. Stuttgart, New York: Georg Thieme, pp 26-35
8. Charbonnier JF, Reboul P, Rougier M, Aubin B, Chassaing JL, Philippe P, Planche R, Hoepfner Petersen HE (1987) Citalopram: an open trial of a highly selective 5-HT uptake inhibitor, administered intravenously to depressed patients. L'Encephale XIII:249-254
9. Faravelli C, Broadhurst AD, Ambonetti A, Ballerini A, De Biase L, La Malfa G, Das M (1983) Double-blind trial with oral versus intravenous clomipramine in primary depression. Biol Psychiatry 18:695-706
10. Gastpar M, Cornu F, Faessler J, Haefliger A, Keller H, von Lerber W, Pagan J, Rem J (1984) Efficacy and tolerability of dibenzepine administered by intravenous drip infusion to severely depressed patients. Neuropsychobiology 11:44-48
11. Guelfi JD, Strub N, Loft H (2000) Efficacy of intravenous citalopram compared with oral citalopram for severe depression: safety and efficacy data from a double-blind, double-dummy trial. J Affect Disord 58:201-209
12. GuyA (1976) ECDEU Assessment Manual for Psychopharmacology. Rockville, Maryland: US Department of Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration
13. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
14. Hyttel J, Arnt J, Sanchez C (1995) The pharmacology of citalopram. Rev Contemp Pharmacother 6:271-285
15. Kielholz P (1982) Eine kombinierte antidepressive Infusionstherapie. In: Kielholz P, Adams C (eds) Antidepressive Infusionstherapie. Stuttgart, New York: Georg Thieme, pp 1-5
16. Kielholz P (1984) Zum Thema. In: Kielholz P, Adams C (eds) Tropfinfusionen in der Depressionsbehandlung. Stuttgart, New York: Georg Thieme, pp 1-7
17. Konstantinidis A, Stastny J, Ptak-Butta J, Hilger E, Winkler D, Barnas C, Neumeister A, Kasper S (2002) Intravenous mirtazapine in the treatment of depressed inpatients. Eur Neuropsychopharmacol 12:57-60
18. Kovács G, Kelemen É, Király L (2000) Cardiologic relations of citalopram drop infusion therapy. Eur Neuropsychopharmacology 10 (Suppl 3):S255 (P.1.091)
19. Laux G, König W, Baumann P (1997) Infusionstherapie bei Depressionen: Ein Leitfaden fur Klinik und Praxis. 4. Aufl: Hippokrates
20. Laux G, König W, Lesch KP, Stein A (1989) Intravenous versus oral treatment of endogenously depressed patients with doxepin. A double-blind study with plasma level determination. Wien Med Wochenschr 139:525-529
21. Lépine JP, Gastpar M, Mendlewicz J, Tylee A, on behalf of the DEPRES Steering Committee (1997) Depression in the community: the first Pan-European study in DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 12:19-29
22. Montgomery SA (1997) Reboxetine: additional benefits to the depressed patient. J Psychopharmacology 11: S9-S15
23. Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389
24. Noble S, Benfield P (1997) Citalopram: a review of its pharmacology, clinical efficacy and tolerability in the treatment of depression. CNS Drugs 8:410-432
25. Pollock BG, Perel JM, Nathan RS, Kupfer DJ (1989) Acute antidepressant effect following pulse loading with intravenous and oral clomipramine. Arch Gen Psychiatry 46:29-35
26. Sallee FR, Vrindavanam NS, Deas-Nesmith D, Carson SW, Sethuraman G (1997) Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. Am J Psychiatry 154:668-673
27. Schöny W (1992) Efficacy and tolerability of citalopram in comparison of parenteral and oral application. Neuropsychiatrie 6:65-71
28. Stahl SM (1998) Using secondary binding properties to select a not so selective serotonin reuptake inhibitor. J Clin Psychiatry 59:642-643
29. Svestka J, Cesková E, Kamenicka V, et al. (1993a) Comparison of intravenous and peroral administration of citalopram in the treatment of major depression. Homeostasis 34:204-205
30. Svestka J, Cesková E, Kamenicka V, Buresova A, Obrovska V, Synek O (1993b) Citalopram (Seropram) in tablet and infusion forms in the treatment of major depression. Cesk Psychiatr 89:331-339
31. Wolfersdorf M, Wendt G, Binz U, Metzger BR, Hole G (1984) Zum Problem der Umstellung von antidepressiver Infusionstherapie auf perorale Medikation. In: Kielholz P, Adams C (eds) Tropfinfusionen in der Depressionsbehandlung. Stuttgart, New York: Georg Thieme, pp 105-115